{"id":35541,"date":"2025-09-10T09:02:58","date_gmt":"2025-09-10T07:02:58","guid":{"rendered":"https:\/\/ggba.swiss\/retinal-imaging-specialist-earlysight-raises-chf-3-1-million-to-accelerate-global-growth\/"},"modified":"2025-09-10T09:04:49","modified_gmt":"2025-09-10T07:04:49","slug":"earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/","title":{"rendered":"EarlySight l\u00e8ve CHF 3,1 millions pour acc\u00e9l\u00e9rer sa croissance mondiale"},"content":{"rendered":"\n<p>Spin-off de l\u2019EPFL fond\u00e9e en 2019 et maintenant install\u00e9 \u00e0 Gen\u00e8ve, <a href=\"https:\/\/www.earlysight.com\/\">EarlySight<\/a> a annonc\u00e9 une extension de son tour de financement avec CHF 3,1 millions suppl\u00e9mentaires, portant le total \u00e0 CHF 6,1 millions. Le financement, qui reste ouvert \u00e0 des compl\u00e9ments jusqu\u2019en octobre, permettra \u00e0 l\u2019entreprise de lancer son produit de deuxi\u00e8me g\u00e9n\u00e9ration, de progresser vers l\u2019approbation r\u00e9glementaire aux \u00c9tats-Unis et de renforcer ses collaborations commerciales.<\/p>\n\n\n\n<p>La plateforme Cellularis Discovery d\u2019EarlySight offre une pr\u00e9cision dix fois sup\u00e9rieure aux outils conventionnels, combin\u00e9e \u00e0 un logiciel d\u2019analyse de biomarqueurs bas\u00e9 sur l\u2019IA, permettant un diagnostic plus pr\u00e9coce et plus pr\u00e9cis des maladies r\u00e9tiniennes. La soci\u00e9t\u00e9 est d\u00e9j\u00e0 utilis\u00e9e par des institutions telles que la LMU de Munich, le r\u00e9seau Swiss Visio et l\u2019H\u00f4pital cantonal de Lucerne, avec un ensemble valid\u00e9 de plus de 18 000 images r\u00e9tiniennes collect\u00e9es aupr\u00e8s de 1 000 patients.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Un impact clinique et commercial croissant<\/h4>\n\n\n\n<p>EarlySight s\u2019attaque \u00e0 un march\u00e9 mondial de l\u2019ophtalmologie estim\u00e9 \u00e0 6 milliards USD, stimul\u00e9 par le vieillissement d\u00e9mographique et la demande croissante en diagnostics de pr\u00e9cision. L\u2019entreprise dispose d\u00e9j\u00e0 d\u2019un carnet de commandes \u00e0 sept chiffres avec des h\u00f4pitaux de premier plan et collabore strat\u00e9giquement avec des soci\u00e9t\u00e9s pharmaceutiques. Sa technologie permet de d\u00e9tecter certaines maladies jusqu\u2019\u00e0 18 mois plus t\u00f4t, un avantage crucial pour des affections comme la d\u00e9g\u00e9n\u00e9rescence maculaire li\u00e9e \u00e0 l\u2019\u00e2ge, o\u00f9 une intervention rapide peut pr\u00e9venir une perte de vision irr\u00e9versible.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">De nouveaux investisseurs et membres du conseil<\/h4>\n\n\n\n<p>Le tour de table a \u00e9t\u00e9 soutenu par les investisseurs existants <a href=\"https:\/\/www.verve.vc\/\">Verve Ventures<\/a>, <a href=\"https:\/\/www.nina.capital\/\">Nina Capital<\/a>, <a href=\"https:\/\/nova-cap.com\/\">NovaCapital<\/a> et <a href=\"https:\/\/www.cadfem.net\/\">CADFEM International AG<\/a>, avec l\u2019entr\u00e9e de la Banque Cantonale de Zurich (<a href=\"https:\/\/www.zkb.ch\/\">ZKB<\/a>) comme nouvel investisseur. EarlySight b\u00e9n\u00e9ficie \u00e9galement du soutien de la Fondation genevoise pour l\u2019Innovation Technologique (<a href=\"https:\/\/www.fongit.ch\/\">FONGIT<\/a>).<\/p>\n\n\n\n<p>La gouvernance s\u2019est renforc\u00e9e avec l\u2019\u00e9lection de Peter Aggersbjerg en tant que vice-pr\u00e9sident du conseil et d\u2019Andy Weymann en tant qu\u2019administrateur ind\u00e9pendant, tous deux apportant des d\u00e9cennies d\u2019exp\u00e9rience en leadership MedTech, strat\u00e9gie clinique et affaires r\u00e9glementaires. \u00ab Ce tour de financement constitue une \u00e9tape cl\u00e9 pour faire d\u2019EarlySight le nouveau standard en imagerie r\u00e9tinienne \u00bb, a d\u00e9clar\u00e9 Timoth\u00e9 Laforest, CEO. \u00ab Nous sommes plus convaincus que jamais que notre technologie am\u00e9liorera la vie de millions de personnes touch\u00e9es par la perte de vision. \u00bb<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EarlySight a lev\u00e9 CHF 3,1 millions suppl\u00e9mentaires, portant son tour de financement \u00e0 CHF 6,1 millions, afin de lancer son produit de deuxi\u00e8me g\u00e9n\u00e9ration et de progresser vers une homologation aux \u00c9tats-Unis.<\/p>\n","protected":false},"author":6,"featured_media":35538,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1148,1188,1181,1228,1141],"class_list":["post-35541","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-financing-fr-2","tag-healthcare-fr-2","tag-medical-devices-fr","tag-optics-fr-2","tag-personalized-medicine-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EarlySight l\u00e8ve CHF 3,1M pour acc\u00e9l\u00e9rer sa croissance mondiale<\/title>\n<meta name=\"description\" content=\"EarlySight a lev\u00e9 CHF 3,1 millions afin de lancer son produit de deuxi\u00e8me g\u00e9n\u00e9ration et de progresser vers une homologation aux \u00c9tats-Unis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EarlySight l\u00e8ve CHF 3,1M pour acc\u00e9l\u00e9rer sa croissance mondiale\" \/>\n<meta property=\"og:description\" content=\"EarlySight a lev\u00e9 CHF 3,1 millions afin de lancer son produit de deuxi\u00e8me g\u00e9n\u00e9ration et de progresser vers une homologation aux \u00c9tats-Unis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-10T07:02:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-10T07:04:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"EarlySight l\u00e8ve CHF 3,1 millions pour acc\u00e9l\u00e9rer sa croissance mondiale\",\"datePublished\":\"2025-09-10T07:02:58+00:00\",\"dateModified\":\"2025-09-10T07:04:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/\"},\"wordCount\":430,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg\",\"keywords\":[\"Financing\",\"Healthcare\",\"Medical Devices\",\"Optics\",\"Personalized Medicine\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/\",\"name\":\"EarlySight l\u00e8ve CHF 3,1M pour acc\u00e9l\u00e9rer sa croissance mondiale\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg\",\"datePublished\":\"2025-09-10T07:02:58+00:00\",\"dateModified\":\"2025-09-10T07:04:49+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"EarlySight a lev\u00e9 CHF 3,1 millions afin de lancer son produit de deuxi\u00e8me g\u00e9n\u00e9ration et de progresser vers une homologation aux \u00c9tats-Unis.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"EarlySight d\u00e9veloppe des instruments d\u2019imagerie oculaire haute performance qui permettent aux m\u00e9decins d\u2019observer les impacts de maladies invisibles avec les outils standards. | \u00a9 EarlySight\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EarlySight l\u00e8ve CHF 3,1 millions pour acc\u00e9l\u00e9rer sa croissance mondiale\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EarlySight l\u00e8ve CHF 3,1M pour acc\u00e9l\u00e9rer sa croissance mondiale","description":"EarlySight a lev\u00e9 CHF 3,1 millions afin de lancer son produit de deuxi\u00e8me g\u00e9n\u00e9ration et de progresser vers une homologation aux \u00c9tats-Unis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/","og_locale":"fr_FR","og_type":"article","og_title":"EarlySight l\u00e8ve CHF 3,1M pour acc\u00e9l\u00e9rer sa croissance mondiale","og_description":"EarlySight a lev\u00e9 CHF 3,1 millions afin de lancer son produit de deuxi\u00e8me g\u00e9n\u00e9ration et de progresser vers une homologation aux \u00c9tats-Unis.","og_url":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-09-10T07:02:58+00:00","article_modified_time":"2025-09-10T07:04:49+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"EarlySight l\u00e8ve CHF 3,1 millions pour acc\u00e9l\u00e9rer sa croissance mondiale","datePublished":"2025-09-10T07:02:58+00:00","dateModified":"2025-09-10T07:04:49+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/"},"wordCount":430,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg","keywords":["Financing","Healthcare","Medical Devices","Optics","Personalized Medicine"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/","url":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/","name":"EarlySight l\u00e8ve CHF 3,1M pour acc\u00e9l\u00e9rer sa croissance mondiale","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg","datePublished":"2025-09-10T07:02:58+00:00","dateModified":"2025-09-10T07:04:49+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"EarlySight a lev\u00e9 CHF 3,1 millions afin de lancer son produit de deuxi\u00e8me g\u00e9n\u00e9ration et de progresser vers une homologation aux \u00c9tats-Unis.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/09\/EarlySight-Device-1180x811-1.jpeg","width":1180,"height":811,"caption":"EarlySight d\u00e9veloppe des instruments d\u2019imagerie oculaire haute performance qui permettent aux m\u00e9decins d\u2019observer les impacts de maladies invisibles avec les outils standards. | \u00a9 EarlySight"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/earlysight-leve-chf-31-millions-pour-accelerer-sa-croissance-mondiale\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"EarlySight l\u00e8ve CHF 3,1 millions pour acc\u00e9l\u00e9rer sa croissance mondiale"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/35541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=35541"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/35541\/revisions"}],"predecessor-version":[{"id":35543,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/35541\/revisions\/35543"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/35538"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=35541"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=35541"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=35541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}